Michael Milos Thornton, Chief Technology Officer at ENDRA Life Sciences Inc. (NDRA), bought 30,000 shares at $1.13 ($34K) on 2019-05-16, disclosed to the SEC on 2019-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NDRA | BUY | 2022-08-24 | $5K | — | Filing → |
| NDRA | BUY | 2022-05-31 | $5K | — | Filing → |
| NDRA | BUY | 2022-05-23 | $6K | — | Filing → |